AMY WERNER: Open Payments
NPI 1770048522 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 19 payments from 9 companies in 2025. Trend: 2023 $247 · 2024 $357 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Novo Nordisk Inc | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: AIRSUPRA, Ozempic, XIFAXAN, Rybelsus, Cologuard Collection Kit, AJOVY, FARXIGA, BEXSERO.
Industry payments across NJ — which companies pay providers there.
